COVID-19 infections, hospitalizations and deaths are all declining and federal health officials could ease guidance on masks soon, the director of the Centers for Disease Control and Prevention said Wednesday.
Dr. Rochelle Walensky, speaking at a White House briefing on COVID-19, said her agency was assessing data and "will soon put guidance in place" that encourages prevention measures while protecting public health and hospitals.
The CDC recommends indoor masking in areas with substantial or high transmission. That includes 97% of U.S. counties, Walensky said.
"We want to give people a break from things like mask wearing when these metrics are better," Walensky said. "And then have the ability to reach for them again should things worsen."
Read more at:
CDC wants to 'give people a break' from mask wearing: COVID-19 updates
Monday, February 21, 2022
Saturday, February 19, 2022
USA: California’s first surgeon general on Covid: ‘Greatest collective trauma’ of a generation
Burke Harris, who resigned this month, said the pandemic is “probably the greatest collective trauma of our generation,” and she, like all Californians she was sworn to serve – will have a long road ahead processing the last two years.
Reflecting on her three years as surgeon general of the most populous US state, Burke Harris warned that “the health consequences of this pandemic will continue, even after the virus itself is contained.”
Read more at: California’s first surgeon general on Covid: ‘Greatest collective trauma’ of a generation | California | The Guardian
Reflecting on her three years as surgeon general of the most populous US state, Burke Harris warned that “the health consequences of this pandemic will continue, even after the virus itself is contained.”
Read more at: California’s first surgeon general on Covid: ‘Greatest collective trauma’ of a generation | California | The Guardian
Friday, February 18, 2022
Germany- Coronavirus restrictions: Germany announces end to most COVID restrictions on March 20
Germany's leaders on Wednesday announced plans to end most of the country's coronavirus restrictions by March 20, a decision that coincided with moves by neighboring Austria and Switzerland to drop many of their curbs sooner.
Read more at: Germany announces end to most COVID restrictions on March 20 - ABC News
Read more at: Germany announces end to most COVID restrictions on March 20 - ABC News
Thursday, February 17, 2022
USA - Covid Immunity: Nearly three-quarters of Americans have some Covid immunity, experts say
Almost three-quarters of Americans are now estimated to have some level of immunity to the Omicron Covid variant that created havoc after it emerged late last year just as people hoped the pandemic was finally waning.
The subsequent Omicron wave that assaulted the US this winter has, however, bolstered its defenses, leaving enough protection against the coronavirus that future surges will probably require much less – if any – dramatic disruption to society, experts reckon.
Read more at: Nearly three-quarters of Americans have some Covid immunity, experts say | Coronavirus | The Guardian
The subsequent Omicron wave that assaulted the US this winter has, however, bolstered its defenses, leaving enough protection against the coronavirus that future surges will probably require much less – if any – dramatic disruption to society, experts reckon.
Read more at: Nearly three-quarters of Americans have some Covid immunity, experts say | Coronavirus | The Guardian
Tuesday, February 15, 2022
Health and the Olympics: Top 10 Health Concerns for Olympic Athletes
Janeiro, Brazil, and they’ve got more on their minds than just the competition. The first Olympic Games to be held in South America come with some unique challenges, along with the usual threats to health and safety that every Olympic Game presents.
“Approximately 10 percent of Olympians get hurt during their days at the games, either while training on site or in actual competition,” reports Scientific American. In addition to injuries, viral, and bacterial infections are creating a serious international buzz. Let’s look at 10 health concerns each athlete in attendance faces this year.
Read more at Top 10 Health Concerns for Olympic Athletes | University of Utah Health
“Approximately 10 percent of Olympians get hurt during their days at the games, either while training on site or in actual competition,” reports Scientific American. In addition to injuries, viral, and bacterial infections are creating a serious international buzz. Let’s look at 10 health concerns each athlete in attendance faces this year.
Read more at Top 10 Health Concerns for Olympic Athletes | University of Utah Health
Saturday, February 12, 2022
Covid Test Cost: How much does a Covid test cost around the world?
In Australia, a federal scheme introduced at the end of January allows pensioners and concession card holders to access up to 10 free rapid antigen tests over three months through their chemist. But the scheme got off to a difficult start, with supply issues hampering attempts to procure the tests. In January the competition regulator raised concerns that rapid antigen tests often cost between A$20 and A$30 (£15-£20) per test and sometimes more than A$70 a test through smaller retail outlets, despite wholesale costs ranging from A$3.95 to A$11.45.
In Belgium the price of an antigen self-test sold in pharmacies is around €6-€8 (£5-£7), more expensive than in neighbouring countries, such as France and the Netherlands, although they are available in Belgian supermarkets for about €3. Prices have come down and are expected to fall further: one big pharmacy chain announced this week they had begun selling tests for €1.99. While a PCR test, which costs about €41, is free for people with symptoms, or may be reimbursed by health insurance, self-tests usually have to be funded by individuals. The Belgian consumer association Test-Achats/Test Aankoop estimated this week that a family of four could spend €250 a month on Covid tests, hand sanitiser and face masks.
Read more at: How much does a Covid test cost around the world? | Coronavirus | The Guardian
In Belgium the price of an antigen self-test sold in pharmacies is around €6-€8 (£5-£7), more expensive than in neighbouring countries, such as France and the Netherlands, although they are available in Belgian supermarkets for about €3. Prices have come down and are expected to fall further: one big pharmacy chain announced this week they had begun selling tests for €1.99. While a PCR test, which costs about €41, is free for people with symptoms, or may be reimbursed by health insurance, self-tests usually have to be funded by individuals. The Belgian consumer association Test-Achats/Test Aankoop estimated this week that a family of four could spend €250 a month on Covid tests, hand sanitiser and face masks.
Read more at: How much does a Covid test cost around the world? | Coronavirus | The Guardian
Wednesday, February 9, 2022
Big Pharma and Corona vaccinations: Putting big pharma in charge of global vaccine rollout was a big mistake : by Nick Dearden
Pfizer has had an exceptionally good pandemic. Today it announced that its Covid-19 vaccine brought in $37bn billion last year, making it easily the most lucrative medicine in any given year in history.
That isn’t all. For a company that was until recently the least trusted company in the least trusted industrial sector in the United States, Covid-19 has been a PR coup. Pfizer has become a household name over the last 12 months. The company was toasted on nights out in Tel Aviv, and there are cocktails named after its vaccine in bars across the world. The US president referred to Pfizer’s chief executive, Albert Bourla, as a “good friend”, and the great man parked his jet next to Boris Johnson’s at last year’s G7 summit in Cornwal
The global vaccine rollout has created levels of inequality so great that many call it a ‘vaccine apartheid’. Pharmaceutical corporations like Pfizer have led this rollout, setting the terms by which they sell vaccines and deciding who to prioritise. Ultimately, their approach affects who does, and does not, receive vaccines.
Right from the start, Pfizer was clear that it wanted to make a lot of money from Covid. The company claims that its vaccine costs just under £5 per dose to produce. Others have suggested it could be much cheaper. Either way, the company is selling doses at a huge profit – the UK government paid £18 a shot for its first order, £22 for its most recent purchase. That means the NHS has paid a mark-up of at least £2bn – six times the cost of the pay rise the government agreed to give nurses last year.
It has been claimed that the company initially tried to pitch their medicine to the US government for an eye-popping $100 a dose. Tom Frieden, a former director of the US Centers for Disease Control and Prevention, accused the firm of “war profiteering”.
Pfizer has sold the vast majority of its doses to the richest countries in the world – a strategy sure to keep its profits high. If you look at its global distribution, Pfizer sells a tiny proportion of its vaccines to low-income countries. By last October, Pfizer had sold a measly 1.3% of its supply to Covax, the international body set up to try to ensure fairer access to vaccines.
Pfizer wasn’t selling many doses to poorer countries, but neither would it allow them to produce the life-saving vaccine on their own, through licensing or patent sharing..
Read more at: Putting big pharma in charge of global
That isn’t all. For a company that was until recently the least trusted company in the least trusted industrial sector in the United States, Covid-19 has been a PR coup. Pfizer has become a household name over the last 12 months. The company was toasted on nights out in Tel Aviv, and there are cocktails named after its vaccine in bars across the world. The US president referred to Pfizer’s chief executive, Albert Bourla, as a “good friend”, and the great man parked his jet next to Boris Johnson’s at last year’s G7 summit in Cornwal
The global vaccine rollout has created levels of inequality so great that many call it a ‘vaccine apartheid’. Pharmaceutical corporations like Pfizer have led this rollout, setting the terms by which they sell vaccines and deciding who to prioritise. Ultimately, their approach affects who does, and does not, receive vaccines.
It has been claimed that the company initially tried to pitch their medicine to the US government for an eye-popping $100 a dose. Tom Frieden, a former director of the US Centers for Disease Control and Prevention, accused the firm of “war profiteering”.
Pfizer has sold the vast majority of its doses to the richest countries in the world – a strategy sure to keep its profits high. If you look at its global distribution, Pfizer sells a tiny proportion of its vaccines to low-income countries. By last October, Pfizer had sold a measly 1.3% of its supply to Covax, the international body set up to try to ensure fairer access to vaccines.
Pfizer wasn’t selling many doses to poorer countries, but neither would it allow them to produce the life-saving vaccine on their own, through licensing or patent sharing..
Read more at: Putting big pharma in charge of global
Subscribe to:
Posts (Atom)